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Summary.-Index sites of breast and cervix uteri were selected from population-
based data held at the West Midlands and Birmingham Regional Cancer Registry,
and the expected numbers of second primary cancers in cervix and breast were
computed (sequence analyses). In the breast series (17,756 patients) a small deficit of
cervical tumours was observed (0=16, E=2-119, O/E=0-76, P>0005), while in the
cervix series (4817 patients) a small excess of breast tumours was found (0=29,
E=23-38, O/E=1P24, P>0 05) over a period of 15 years.
A theoretical statement of the combined risk of the 2 tumours occurring in the
same individual of a general population was developed and was compared with the
practical approach of summing the sequence analyses (complementary analysis).
Complementary analysis indicated that there was no excess of women with the 2
primary tumours (0=45, E=44-57, O/E=1-01) and that cancers of the breast and
cervix uteri are not aetiologically related.
OVER THE LAST HUNDRED YEARS, the
study of multiple primary cancer has pro-
gressed from anecdotal report to quantita-
tive epidemiological assessment. Clinically,
a knowledge ofthe incidence ofsubsequent
tumours is important in determining the
prognosis and future management of the
cancer patient. An epidemiological ap-
proach to the problem, it was hoped,
would lead to a better understanding of
the aetiology of the disease. For example,
a high risk for subsequent tumours might
suggest that cancer patients are predis-
posed to the disease because of the pre-
sence of some inherited or acquired factor
that promotes tumour formation. On the
other hand, a decreased risk might suggest
that the presence of one tunmour confers
some immunity against further tumours.
Finally, if the risk of subsequent tumours
is no different from that of first primaries,
it might be inferred that cancers are the
result of chance events and arise inde-
pendently.
Published reports so far suggest that
there is no general predisposition to the
disease, the demonstrated increases in risk
being site-specific. Once associations be-
tween pairs or groups of sites are estab-
lished, it might then be possible to explore
in more detail the aetiological factors
which may be common to tumours at these
sites.
Evaluation of risk, however, was de-
pendent on the development ofan accurate
statistical method which could compare
incidence rates for cancer in the "cancer"
population with those in the general popu-
lation. The problem here was 2-fold: first,
because of the relative rarity of patients
with multiple tumours, a long period of
time was required to accumulate a number
sufficient for detailed analysis; second,
reliable valid cancer rates for a general
population were also essential. Hospital-
basedtumourregistries were able to supply
large data bases for analysis but it was
only with the establishment ofpopulation-
based registries that both difficulties were
resolved; more cases became available andP. PRIOR AND J. A. H. WATERHOUSE
incidence rates for the population under
consideration could be computed.
A conventional method of analysis is
now well established and has been suffi-
ciently described elsewhere (Schoenberg
et al., 1969). In essence, an index site is
selected and the length of survival to
death or to a termination date is deter-
mined for each patient with the index
tumour. Age, sex and site-specific inci-
dence rates are applied to the resultant
''patient years" ofobservation to compute
the number of tumours which might be
expected to occur before the termination
date of the survey, the basic assumption
being that a person who has suffered and
survived one tumour is at the same risk
for a second as a comparable individual in
the general population for a first primary.
The expected numbers (E) are then com-
pared directly with the number of cases
observed (0) during the period ofstudy.
Several centres have now reviewed their
data, but the results are far from consis-
tent, although they were produced from
relatively large, reputable data sources
and authenticated incidence rates had
been used. The level of follow-up was
claimed to be high, > 95%. Why then
should results be so conflicting?
These results suggested that minor
differences in methodology could wholly
or in part account for the discrepancies
between the various surveys, and that it
might be more profitable to consider
afresh the analytical approach, rather than
to strive for greater perfection in the data.
TheBirmingham MultiplePrimaryTumour
Survey
The Birmingham RegionalCancerRegis-
try records cancer diagnoses and clinical
information for a population of just over
5 million. The Registry has operated for
20 years as a regional registry, and for a
previous 20 years on a less comprehensive
basis. A large body of data was therefore
available for analysis, and careful records
had been kept (from the earliest years)
ofpatients with multiple primary tumours.
When a survey of multiple primary
tumours was first undertaken the conven-
tional approach to analysis was not ques-
tioned. The methodology used in the first
analysis (Prior & Waterhouse, 1977) was
comparable with those in previously pub-
lished reports. As the survey progressed,
however, application of the statistical
methodology raised additional questions
which led to suggested refinements and
eventually to a deeper reappraisal of the
conventional approach.
One obvious point of difference between
the various published surveys appeared
when an analysis of bilateral breast
tumours was carried out using the Bir-
mingham data (Prior & Waterhouse,
1978). This difference concerned the defini-
tion and statistical treatment of coinci-
dental (or synchronous) tumours. A modi-
fication to the "conventional" approach
to analysis which allows for the inclusion
of coincidental diagnoses has been pre-
sented elsewhere (Prior, 1974; Prior &
Waterhouse, 1981). A model was described
as a basis for recomputing expected
numbers of tumours to allow for the
anticipatory nature of the diagnoses.
Although the model was, in principle,
considered to be a sound approachi, it was
difficult to assess its effectiveness in the
presence of an excess risk of second
primary tumours. When in consequence
2 dissimilar and, it was hoped, aetio-
logically independent sites were chosen to
test the model further, it was realised that
the selection ofan index site was the funda-
mental step in initiating the analytical
process. This step introduced an implicit
concept of sequence, such that only the
event of Tumour B following Tumour A
was considered. Although the converse
sequence, Tumour A following Tumour B,
was acknowledged, it was treated separ-
ately. Within a specified period of time,
however, the 2 distributions overlap
and coincidental diagnoses represent a
special case of the joint distribution. It
seemed worth while, therefore, to re-
consider the implications of the conven-
tional sequence-approach to analysis in
terms of an index site and to assess its
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validity and limitations. Sequence analysis
is essentially patient-orientated. An epi-
demiological approach might attempt to
describe 2 distributions of tumours
arising in a known population over a
specified period oftime, an approach which
might be possible with population-based
data.
These general considerations were, how-
ever, prompted by the results of the
analyses for breast and cervix uteri.
Initially, each sequence of tumours that
is, cervix followed by breast and breast
followed by cervix was investigated
using the conventional approach, together
with the appropriate models to allow for
the inclusion of coincidental diagnoses.
Such an approach will be referred to below
as sequence analysis. The results obtained
from the sequence analyses appeared to
support the applicability of the model
with respect to coincidental diagnoses,
but overall the results were anomalous:
one sequence showed an excess, the other
a deficit of second primary tumours. The
nature of the discrepancies suggested the
possibility of combining the 2 analyses
in a way that could possibly answer the
more general questions posed above. The
combined approach will be referred to
below as conmplementary analysis. Finally
an attempt was made to derive a general
theoretical expression which would de-
scribe the concurrent incidence of 2
tumours and which could be used to test
the validity of the ad hoc method of
complementary analysis.
MATERIALS AND METHOD
Seqatence analyses for breast and cervix.
The first series of patients comprised 17,756
registrations for breast cancer between 1950
and 1964. A second series consisted of 4817
registrations for cancer of cervix uteri over
the same period. All patients were followed
to the 1965 anniversary date or to death if
this occurred earlier. and the period of sur-
vival for each individual was computed. An
array of "women-years" at risk -was con-
structed for each series in terms of age at and
years from the diagnosis of the first primary.
Age-specific incidence rates for cancer of the
breast and cervix were computed from the
mean number of annual registrations (1960-
1962) together with population figures for the
West Midlands region obtained from the
Registrar General's Census Report (1961).
Age-specific rates for cervix were applied to
the array of "women years" at risk for the
breast series to obtain the number of cervical
tumours that might be expected to occur
after the diagnosis of breast cancer. Simi-
larly, the expected number of subsequent
breast tumours in the series of patients with
cervical cancer was computed. By using 2
models, one for each sequence, the expected
numbers were modified to allow for the in-
clusion of coincidental diagnoses.
Patients presenting for either surgical or
radiation treatment to the cervix would be
subjected to a general examination, when
tumours in the preclinical phase might be
found in the breast. It was considered that
the clinical situation would be similar to that
obtaining in the bilateral breast survey, in
which a value of 16 months for the preclinical
period was suggested. The same value was,
therefore, used in the model for the cervix
series. When breast presented as the first
primary, it was doubtful that routine screen-
ing of the cervix would be included in the
general examination, so that only sympto-
matic tumours would be found. In the model
for the breast series, therefore, the pre-
clinical period was taken as the median dura-
tion of symptoms for cervix cancers, i.e.
4 months.
Once the patient had been treated for the
first primary, it seemed doubtful that pre-
clinical tumours at a site at a distance from
the first primary site would be discovered at
follow-up examination, not because of
negligence but because the investigation of
an unrelated site might arouse undue anxiety
in the patient. A value of 2 years was, there-
fore, used for the second parameter in both
models, after which time it was considered
that expected numbers obtained by the con-
ventional method wrould be satisfactory.
More detailed explanations of the sequen-
tial method and use of the model have been
given previously (Prior & Waterhouse, 1977,
1978).
RESULTS
Sequence analyses
C1onsidering first the coincidental diag-
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TABLE I. Coincidental diagnoses of breast
and cervix: expected numbers predicted
from the models, with total observed
numbers
Age at Total
1st Breast-*Cervix Cervix--Breast
primary E E E 0
15-44 0304 1 042 1-346 2
45-50 0-844 3 271 4-115 4
60+ 1-277 4-296 5-573 5
All ages 2-425 8-609 11-034 l1
O =Observed number of second primary tumours.
E =Expected number of second primary tumours.
noses, Table I shows the expected number
of second primary tumours predicted by
the models for each sequence of tumours
by age-range. The total expectation for
each age-range is also compared with the
corresponding observed numbers. Overall,
11-03 tumours were expected and 11
observed. A similarly close correspondence
between observed and expected numbers
was also found for each age-range.
On the null hypothesis, that breast and
cervix tumours arise independently in the
population, the model was successful in
predicting the number of coincidental
diagnoses that were likely to be made.
The results also suggested that it would
be possible to apportion the coincidental
tumours between the 2 series in accord-
ance with expected numbers: 9 to the
cervix series, 2 to the breast series, assum-
ing that observed numbers must be
integers.
Having apportioned coincidental tu-
mours and completed the analyses, the
final comparisons revealed (Table II) a
TABLE II.-Observed and expected numbers
of second primary tumours for the index
sites of breast and cervix
Sequence
Breast -*Cervix
Cervix -*Breast
Total
0
16
29
45
E P
21-19 > 0-05
23-38 > 0-05
44-57 > 0-05
deficit of cervical tumours in the breast
series and an excess of breast tumours
after a first primary in cervix. In Fig. 1
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FIG. I.-Cumulative observed (-) and ex-
pected (---) numbers of second primary
tumours by year from first primary diag-
nosis for sequence analyses: breast to
cervix (top) and cervix to breast (bottom).
primary are plotted for each sequence.
The graphs show that despite the good fit
obtained for co-incidental tumours, ob-
served and expected numbers gradually
diverged over the period of observation.
Neither discrepancy, at the end point, was
statistically significant, and might there-
fore be considered an artefact of the
methodology. However, if 2 sites for
which a positive association was of aetio-
logical significance were being considered,
a spuriously high or low estimate of risk
might be obtained ifonly one sequence was
considered.
Complementary analysis
Looking again at Table II, it can be
seen that the expected total number of
cases with 2 primary tumours was re-
markably close to the total number
1.
. - - L.. .L
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FIG. 2.-CumulativH e observed ( ) and ex-
pected (- ) numbers of seconcl primary
tumours by year from first primary (liag-
nlosis for complementary ainalysis: cervix
and breast, all age groups.
observed. It seemed possible, therefore,
that a combination of results from the
2 sequences offered a plausible approach
to assessment. The implication of this
heterodox postulation, however, was that
the sequence of tumours was irrelevant.
Apart from the problem of sequence, the
overall result did appear to answer the
more general question with the solution
that, during the period 1950-1965, 45
individuals were observed to develop the
2 tumours when 44-5 were expected.
The resultant relative risk of IP01 indicated
that secondary primary tumours were de-
veloping at the same rate as the respective
first primaries in the general population,
and were independent.
Pursuing the idea of combination,
cumulative expected numbers from the 2
sequences (Fig. 1) were added together by
year from first primary. They are com-
pared with the corresponding observed
numbers, combined in the same wav in
Fig. 2, which demonstrates a close fit
between 2 lines over the whole period of
observation. Further, a similar corre-
spondence was found for each of the 3
age-ranges (Fig. 3). Although some varia-
tion within the age-ranges is evident, the
relative risk across all ages at each year is
IUMUL
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FJG. 3. Cumulative observed ( ) an(l ex-
pected (---) numbeis of second primary
ttimours by year from first primary diag-
nosis for complementary analysis: cervix
and breast, according to age at first primary
(liagnosis.
15
remarkably close to 1.0. The final relative
risks were 1-13 (ages 15-44), 1'01 (ages
45-59) and 0 96 (ages 60 + ), with a relative
risk of 1-01 over all ages. In relation to
age at second primary it was also found
that the lines for cumulative observed and
expected numbers lay substantially close
together (Fig. 4).
Theoretical expression for the combined risk
A paper introducing a new form of age
standardization for cancer incidence rates
proposed the use of the cumrnlative rate,
defined either as a directly age-standard-
ized incidence rate or as an approximation
to the cumulative risk over age. Rates for
individual cancer sites were used to exem-
plify the approach (Day, 1976). Extension
of the procedure to include more than one
site seemed possible, and a theoretical
100o0o
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FIG. 4. Cumulative observed ( ) and ex-
pected (- ) numbers of second primary
tumours by age at second primary diag-
nosis for complementary analysis: cervix
and breast.
expression for the incidence of 2 pri-
mary tumours in a general population is
presented in Table III.
Considering 2 conditions arising inde-
pendently in the same population, be-
tween age t and (t + St), the increase in the
number 8z ofindividuals in the population
with both conditions is given by Equation
(1). The number of individuals without
Condition A, i.e. x(t), could also be
expressed by Equation (2). Thus, the total
number affected by Condition A at age t
will be equal to N - x(t) as given by Equa-
tion (3). For small values of A(t) it has
been shown that the approximation in
Equation (4) is acceptable (Day, 1976). By
the same reasoning, the number of indi-
viduals with Condition B at age t is given
approximately by Equation (5). Substitut-
ing for N-x(t) and N-y(t) in Equation 1,
the number of individuals with both
conditions at age t can now be expressed
20- 30- 40- 50- 60- 70- 80- 90-
AGE at St. PRIMARY 01 AGNOSI
FIG. 5. Expected numbers ofsecond primary
tumours by age at first primary diagnosis
for the first 5 years of observation: cervix
ancd breast computed from women years
at risk ( ) and theoietical approach (---).
by Equation (6), which is of the differen-
tial form:
d(uv)=u dv+ v du
Integrating over age, the proportion of
the initial population affected by both
conditions is obtained from Equation 7.
The initial assumption was one of inde-
pendence between conditions and thus
Equation 7 is comparable to the multi-
plication of probabilities for 2 indepen-
dent events. If o(t) and /(t) represent the
cumulative rates up to age t for Condition
A and Condition B respectively, the num-
ber with both conditions can be expressed
as the product of the initial population
and the 2 cumulative rates (Equation
8). In its final form the expression has the
elegance of simplicity and is clearly
independent of the sequence of events.
so5o
* s s s s
628MULTIPLE PRIMARY CANCERS OF BREAST AND CCU
TABLE III.-Theoretical statement for 2
conditions (A and B) arising indepen-
dently in a generalpopulation (N)
N =initial population; t=age (years)
x(t) =number not affected by condition A at age t
y(t) =number not affected by condition B at age t
A(t) =annual incidence rate for condition A
B(t) =annual incidence rate for condition B
z(t) =number of individuals with both conditions up
to age t
{[N-x(t)]B(t) +[N-y(t)]A(t) }St =8z (1)
x(t) =N exp [-jt A(t) dt] (2)
lt
=N A(t) dt (4)
N-y(t)=N tB(t) dt (5)
0
([N''A(t) dt]B(t)+[N{t B(t) dt]A(t))&t=3z (6)
rtA(t) dtx B(t) dt=z( ) (7)
z(t) =Na(t)fl(t) (8)
Comparison between the theoretical approach
and complementary analysis
With the data available, application of
the integrated expression is not easy. Even
in long-established registries the complete
life experience of one birth cohort is not
yet available, and information must be
gleaned from the partial experience of
many cohorts in order to obtain sufficient
numbers for analysis. The result is that a
valid value for N, the initial population,
is not immediately obvious and, although
an attempt to compute a single "equiva-
lent" birth cohort for the whole series was
made, it was abandoned as infeasible
because the differing contributions from
the various real birth cohorts remained.
A second, more circumscribed, attempt
treated each 5-year age group (of ages t
to t+4 years) ofthe series separately, and
an "equivalent" cohort at age t was com-
puted for each. The procedure is set out in
Table IV. Working from the breast and
cervix data separately, a source popula-
tion at age twas obtained fromthe number
of cases and the age-specific incidence
rates, and a mean of the 2 results was
taken. One fifth ofthis number was taken
as the initial cohort at age t.
Although it was intended to integrate
over the full 15 years of observation for
each age group, several difficulties were
encountered. Apart from the birth-cohort
effect, the period of follow-up was de-
pendent on calendar year; registrations
from 1950 could contribute a full 15 years,
while those from 1960 would contribute
only 5 years. In addition, the theoretical
expression did not allow for deaths from
cancer or other causes and became in-
creasingly less accurate after 60 years of
age. However, it was considered that the
final form ofthe expression remained valid
in principle.
It was proposed, therefore, to make the
comparison for only the first 5 years of
observation, when it was considered that
the inaccuracies, although not excluded,
would be at a minimum. For each cohort
(at age t) incidence rates were summed
from t to (t+ 4), first for breast and then
for cervix. The product of the sums was
multiplied by the initial cohort, N(t), to
give an approximation to the number of
women with the 2 tumours during the
5-year period. The results are displayed
in Fig. 5 as the theoretical expected number
TABLE IV.-Estimation from the breast and cervix of an "equivalent" birth cohort at age
t years
Breast series
Cancer
No. of incidence
Age cancer rate
(ttot+4) cases (per 105)
45-49 2213 113-57
50-54 2171 123-46
55-59 2165 135-89
Population estimate (106)
From From
breast cervix Cohort
series series Mean at age t
1-95 2-10 2-02 0 40
1-76 2-14 1-95 0 39
1-59 1-56 1-58 0-32
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(broken line). Between the ages of 50 and
54, for instance, the expected number of
individuals with the 2 tumours was 3-4.
For the age group 50-54 years it was
computed, on the basis of "women years"
at risk, that 1-85 individuals from the
breast series would be diagnosed with a
cervical tumour, and that among cervix
cancer patients in the same age group 1-84
would develop a breast tumour. In all,
then, 3 7 individuals would develop the
2 tumours over the 5-year period. The
combined value for each age group is
plotted in Fig. 5 as expected number-
"women years" at risk (solid line). Because
the data for the sequence analyses were
arranged by 5-year group, the age-ranges
covered by each method do not exactly
coincide. This discrepancy has been al-
lowed for by plotting points at mean age
of diagnosis of a first primary. Despite
some fluctuations, the 2 lines lie remark-
ably close together.
From these results it seemed reasonable
to conclude, assuming the theoretical
expression to represent a true description
of associated risks, that the complemen-
tary method offers a more accurate ap-
proach to analysis than sequence analysis.
DISCUSSION
The concept of sequence
The conventional method ofanalysis for
multiple primary tumoursusing indexsites
and morbidity rates is a logical develop-
ment of early attempts using mortality
rates. Mortality analyses embodied an
implicit sequence of events: diagnosis of a
first primary tumour (Event A) was
followed by death from a second primary
(Event B). This approach is common in
epidemiological investigations, where, for
instance, Event A could be the diagnosis
of a specific disease or first exposure to a
suspected hazard. Event B, again,would
be death, and only one sequence would be
possible: A--B.
When morbidity rates, in place of
mortality rates, became available for
multiple primary analysis, Event B then
became the diagnosis of a second primary
tumour. Although it was appreciated that
for 2 tumour sites the converse sequence
-that is, B-+A-could occur, the ap-
proach to analysis remained the same:
each sequence was investigated separately.
In accepting the theoretical statement
ofrisk and, in consequence, the method of
complementary analysis, the concept of
sequence becomes irrelevant. This concept
is so firmly entrenched in the epidemio-
logical approach that it is difficult to
dismiss it on what might be considered
slender evidence. Nevertheless, it is easy
to see in retrospect that the concept of
sequence is a natural consequence of
selecting an index site as an arbitrary
reference. More precisely the analysis is
based on the date of diagnosis of the first
primary, the justification being that this
is the only point in time that is known with
any degree of accuracy. In developmental
terms it is, however, a point relatively
near to the end of the tumour's history.
Because of the long latent period for solid
tumours, many of the cancers of breast
and cervix arising in the same individual
will be well on the way to maturity before
the diagnosis of the first primary, and if
the tumours are developing independently
there is no basis for a necessary sequence.
The result is that allocation of the indi-
vidual to either the cervix or the breast
series would be random.
Validity of complementary analysis
Two points of uncertainty remained,
concerning the validity of complementary
analysis: the first is whether the method
has general applicability to other site
combinations, and the second is whether
the demonstrated independence for breast
and cervix is an acceptable result. The
possibility of the result being a chance
effect could be tested in the practical
situation using other site combinations.
The acceptability of the result was ques-
tioned because ofepidemiological evidence
that breast-cancer patients differed in
many respects from those with cervical
cancer, the mostimportant being, perhaps,
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age at first pregnancy. A pregnancy com-
pleted early in the reproductive phase was
thought to confer some protection against
breast cancer, whereas, with respect to
cervical cancer, an early pregnancy, with
its possible social and biological implica-
tions, may represent a factor of risk. In
consequence anegative association between
the sites might have been predicted. On
the otherhand, apositive association might
have been anticipated as the result of a
promotional effect of hormones on the
2 hormone-responsive tissues, similar
to the effect found for breast and ovary
and also for breast and corpus uteri.
It is difficult, however, to visualize an
aetiology consistent with results showing
an excess of subsequent tumours for one
sequence and a deficit for the other.
On balance, we consider that the dis-
crepanciesrepresent methodologicalrather
than aetiological effects and that comple-
mentary analysis can be useful in minimiz-
ing artefactual differences. In our experi-
ence the method has given satisfactory
results for several site pairs.
Although we have suggested above that
in the context of complementary analyses
sequence could be unimportant, in one
situation itishighlyrelevant. Forexample,
if the presence of or treatment to a first
primary results in the induction of a
further tumour at a site which may other-
wise be independent of the first, the in-
crease in risk would apply to only one
sequence. However, a latent period would
be implicit in this pattern of development
which should give, in turn, a distinctive
pattern of incidence of the 2 tumours
in the complementary analysis, with
observed numbers beginning to diverge
from the expected number after a latent
period. Associations of this type might
include either leukaemia or colon cancer
developing as a result of irradiation to the
genital organs, or lymphangiocsarcomas
following radical mastectomy for breast
cancer.
In interpreting the findings from studies
of multiple primary neoplasms, we are
cautioned in the literature "to distinguish
between real and artefactual relationships
and between biological and statistical
significance" (Schoenberg, 1975). We have
attempted to show here that artefactual
discrepancies can result if only one
sequence is examined, and that comple-
mentary analysis can resolve some of the
statistical problems, as well as providing a
fresh approach to the biological problems.
The survey of Multiple Primary Malignant
Tumours is supported by the Cancer Research
Campaign.
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